Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...

A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering from ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Dementia often affects memory, thinking, behavior and daily functioning — now, a new case study reveals a novel symptom that shouldn’t be overlooked. Nearly 7 million Americans and more than 55 ...

Overland Park students are working in a special program where they're re-imagining what it means to take care of your brain.

While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

ICE has released a 79-year-old Cuban woman from the Eloy Detention Center, after she spent nine months there. Julia Benitez ...